Supplier
DENERSOL SAS
R/219400840018
DEIRUPEcrawl4aiMapsIMPO
$ 2.334.000
Total received
- Contracts
- 5
- Agencies that bought from them
- 2
- Average contract
- $ 466.800
- Years with activity
- 2
- First contract
- 18 abr. 2024
- Last contract
- 25 mar. 2025
DENERSOL SAS received $ 2,3 M from the Uruguayan state across 5 awards between 2024 and 2025. It sold to 2 agencies. Its largest buyer is Banco de Previsión Social, with 98% of recorded spending.
What it bid for, and against whom
Open data publishes only the winner, so losing bids appear nowhere. This comes from the bidders each purchase record publishes. It covers the 5 calls of this company we have checked so far, not all of them: the scan advances gradually.
4/5won of those checked
80%win rate
20.8rivals per call, on average
Who it meets most often
- MEGALABS URUGUAY S A5 times
- LABORATORIOS CELSIUS S A4 times
- ADIUM URUGUAY SOCIEDAD ANONIMA3 times
- BRANDT LABORATORIOS DEL URUGUAY S A3 times
- ICU VITA S A3 times
- LABORATORIO GADOR S A3 times
- LABORATORIO LIBRA SOCIEDAD ANONIMA3 times
- URUFARMA S.A.3 times
State Suppliers Registry (RUPE)
ACTIVO- Legal name
- DENERSOL SAS
- Fiscal domicile
- Montevideo MASSINI RAMON 3006 View on Google Maps
Source: ARCE — Registro Único de Proveedores del Estado (RUPE), open data. Cross-referenced to the supplier by RUT.
Revenue by year
Who buys from them
Agencies ranked by amount awarded to this supplier.
- Banco de Previsión Social$ 4,9 M
- Dirección General de la Salud$ 90.000
Client concentration
98%
Banco de Previsión Social
How much of their revenue comes from their largest buyer.
Contracts
View all| Subject | Agency | Date | Amount |
|---|---|---|---|
| TOXINA BOTULINICA (INYECTABLE) · TAMSULOSINA (COMPRIMIDOS)… | Banco de Previsión Social | 25 mar. 2025 | $ 3,2 M |
| TOXINA BOTULINICA (INYECTABLE) · DESONIDA (CREMA) | Banco de Previsión Social | 16 ene. 2025 | $ 411.863 |
| TOXINA BOTULINICA (INYECTABLE) | Dirección General de la Salud | 30 may. 2024 | $ 45.000 |
| SOLUCION HIPERTONICA DE CLORURO DE SODIO · TOXINA BOTULINICA (INYECTABLE) | Banco de Previsión Social | 29 abr. 2024 | $ 1,3 M |
| TOXINA BOTULINICA (INYECTABLE) | Dirección General de la Salud | 18 abr. 2024 | $ 45.000 |